Effects of ITPA and IFNL4 polymorphism during simeprevir, peg-interferon, and ribavirin combination and sofosbuvir and ribavirin combination treatment for chronic hepatitis C (1) Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C (2) ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C

k7554_2

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k7554_2.pdf

https://hiroshima.repo.nii.ac.jp/record/2004018/files/k7554_2.pdf

ファイル	ライセンス
k7554_2.pdf (171.2 kB) sha256 10d525661f7abcf70f2c29aa532201f1f0c83db055ce5b589f27c9b0aad7a437

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays